Fig. 5From: Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathwayhrCCN5 treatment suppresses the mammosphere forming ability of leptin treated MCF-7 cells. a Representative images of MCF-7-mammospheres following leptin (3.125 nM) treatment in the presence or absence of hrCCN5 (10.29 nM). b Bar graph represents the number of mammospheres of different sizes in the experimental set-up indicated. Error bars indicate mean ± SEM of three independent experimentsBack to article page